By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GI Dynamics 

Boston  Massachusetts    U.S.A.
Phone: 617-454-6025 Fax:


Medical Device

Company News
GI Dynamics (GID.AX) Release: New Data Presented At American Diabetes Association Demonstrate Early Effect Of Endobarrier Therapy On Glucose Control And Bile Acid Regulators 6/8/2015 11:28:39 AM
GI Dynamics (GID.AX): Appendix 4C Quarterly Report Quarter Ended 31 March 2015 4/30/2015 12:41:43 PM
GI Dynamics (GID.AX) Stock Freefalls After FDA Halts Trial 3/6/2015 6:40:56 AM
GI Dynamics (GID.AX) To Axe 10% Of Workforce 12/10/2014 6:21:05 AM
GI Dynamics (GID.AX) Resumes Shipments Of EndoBarrier® Product 12/1/2014 12:37:15 PM
GI Dynamics (GID.AX) Shares Belted Over Suspension Of Obesity Device In Europe 10/9/2014 7:10:33 AM
GI Dynamics Release: New Data Presented At EASD Demonstrate Robust Cardiometabolic Health Effects Of EndobarrierĀ® Therapy In Obese People With And Without Diabetes 9/17/2014 11:29:12 AM
GI Dynamics Taps Ex-ATS Medical, Inc. (ATSI) Chief For CEO Job 8/28/2014 9:32:42 AM
GI Dynamics Announces New Findings That Show Elimination Of And Reduced Reliance On Insulin By Patients Treated With Endobarrier® Therapy 5/16/2014 7:50:00 AM
GI Dynamics Announces New EndoBarrierĀ® Data from Research with GlaxoSmithKline (GSK) Presented during Digestive Disease Week 5/5/2014 7:49:31 AM